Search PubMed⌕ Search

PubMed · 9693713

Rats receiving the slimming agent oleoyl-estrone in liposomes (Merlin-2) decrease food intake but maintain thermogenesis.

Abstract

Oleoyl-estrone given i.v.--incorporated in liposomes to mimic lipoprotein delivery--(Merlin-2) to normal weight rats, induces a dose-dependent weight loss. Analysis of body composition showed that body protein concentration was preserved and fat stores wasted. The respiratory quotient was consistent with the massive oxidation of body fat, since the diet contained practically no lipid. Appetite was affected by Merlin-2, and thus food intake showed a transient decrease. But oxygen consumption (and basal metabolic rates) was kept practically unchanged at the levels of the controls, i.e. higher than needed to oxidize the food ingested during the weight loss period. Brown adipose tissue uncoupling protein levels were proportionally preserved with a 2-week treatment, but it lost a substantial amount of lipid. In conclusion, Merlin-2 is a slimming agent with considerable potential given its powerful fat-wasting action, since it maintains thermogenesis despite lowered energy intake.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D Sanchis, F Balada, C Picó, M M Grasa, J Virgili, C Farrerons, A Palou, J A Fernández-López, X Remesar, M Alemany. 1997. Rats receiving the slimming agent oleoyl-estrone in liposomes (Merlin-2) decrease food intake but maintain thermogenesis.. https://doi.org/10.1076/apab.105.7.663.11391

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Rapidly decellularized adipose tissue induces soft tissue vascularization in potential anatomical spaces.

Decellularized tissues provide biological cues owing to the wealth of structural and regulatory factors that promote angiogenesis, adipogenesis, and myogenesis and facilitate neurite outgrowth. Here, we demonstrated the advantages of decellularized adipose tissue (adipoECM) over defined collagen-based biomaterials for host tissue integration. Three batches of human adipose tissue were decellularized using a rapid decellularization protocol and analyzed using mass spectrometry. To assess the biological activity of the decellularized materials, adipoECM and a reference standard of care biomaterial (Integra®DRT, also containing collagen I and glycosaminoglycans) were implanted subcutaneously, but far from the wound bed (in anatomical potential spaces) of immunocompetent BALB/c mice. The mice were euthanized in the acute (1 day) and chronic (day 60) inflammatory reaction phases, followed by biomaterial excision and Masson’s trichrome immunohistofluorescence imaging of the paraffin-embedded specimens. Each batch of processed tissue passed a quality control check, showing a low level of donor genomic DNA, lack of nuclei, lipids, endotoxins, and bacterial contamination. Mass spectrometry revealed that all batches of decellularized tissue mainly contained collagen I and, to a lesser degree, collagen III, collagen IV, collagen V, laminin, fibrillin, fibronectin, tenascin, and elastin. No acute inflammatory reaction was observed in either material one day post-transplantation. At 60 days post-implantation, different cell types were detected in adipoECM specimens, whereas Integra®DRT remained acellular. Additional immunohistochemical staining of adipoECM revealed CD31-positive cells in the blood vessels. Mesenchymal (CD90 positive) and myeloid (CD14 positive) cells were also detected. Primary cell types involved in soft tissue healing and remodeling were found in the adipoECM-treated group. The ingrowth of blood vessels and mesenchymal cells confirmed the effective integration of adipoECM with host tissues. Our results demonstrate that decellularized adipose tissue implanted away from the wound bed possesses contextual biological activities that promote efficient integration with host tissues.

Adipose Tissue↗

Interaction between tris(4-chlorophenyl)methanol and the human androgen receptor in vitro.

The interaction between tris(4-chlorophenyl)methanol (TCPM), an environmental contaminant of uncertain origin, and the human androgen receptor was examined in vitro using a previously characterized human androgen receptor reporter gene assay in which PC-3 LUC(AR+) cells respond to 5alpha-dihydrotestosterone (DHT) with enhanced luciferase activity. In two preliminary studies, TCPM (1 microM) had no effect on androgen receptor activation in the absence of DHT (50 pM), but DHT-mediated activation of the androgen receptor was decreased more than 90% by TCPM at 1 microM. This was not due to an effect of TCPM on cell viability since, with TCPM concentrations of 0.1 and 1.0 microM, cell viability was 111 and 102%, respectively, but at 10 microM TCPM, cell viability was reduced to 60% compared with controls. For kinetic studies of the effects of TCPM on androgen receptor activation, DHT was added at 0, 5, 25, 50, 75, 100, 250 and 500 pM and the TCPM concentrations used were 0, 1, 10, 100, 300 and 1000 nM. This range incorporated the levels of TCPM in human adipose tissue, where concentrations up to 55 nM (20 ng/g lipid) have been measured. TCPM increased the value of the K(m(app)) of the androgen receptor for DHT 4-6-fold with little or no effect on the V(max(app)). Slope and intercept replots revealed that TCPM inhibited the DHT-mediated activation of the androgen receptor in a competitive manner with K(i(app)) values of 0.26, 0.26 and 0.20 microM compared with respective K(m(app)) values of 9.8, 3.1 and 3.9 pM. Thus, TCPM is a competitive antagonist of human androgen receptor activation and the value of the K(i(app)) indicates that TCPM would be approximately 10-50 times more potent as an inhibitor than the previously identified androgen receptor antagonists p,p'-DDE and vinclozilin and also, the K(i(app)) values (200-260 nM) are very close to the concentration of TCPM found in the adipose tissue of some humans (55 nM).

Adipose Tissue↗

Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease?

BACKGROUND: The mechanisms by which obesity increases the risk of atherosclerotic cardiovascular disease (CVD) are poorly understood. In experimental models, leptin, a hormone produced by adipose tissue, has been shown adversely to affect vascular health. Therefore, we tested the hypothesis that high leptin concentrations are associated with lower arterial distensibility, an index of circulatory function relevant to the atherosclerotic process. METHODS AND RESULTS: Noninvasive, high-resolution, vascular ultrasound was used to measure brachial artery distensibility in 294 healthy adolescents (aged 13 to 16 years) who had a broad range of body mass indexes. Fat mass was measured by bioelectric impedance analysis; fasting serum leptin concentration by radioimmunoassay; and lipid profile, fasting insulin, glucose, and C-reactive protein concentrations by standard laboratory techniques. Higher leptin concentrations were associated with impaired arterial distensibility (regression coefficient, -1.3% change in arterial distension per 10% increase in leptin; 95% CI, -1.9% to -0.8%; P<0.001). This association was independent of fat mass, blood pressure, and C-reactive protein, fasting insulin, or LDL cholesterol concentrations. CONCLUSIONS: Elevation in leptin was associated with impaired vascular function, independent of the metabolic and inflammatory disturbances associated with obesity. Our observations are consistent with data from experimental models and suggest that high leptin concentration is an important mechanism for the adverse influence of body fatness on CVD.

Adipose Tissue↗